Rebecca Taub

Dr. Rebecca A. Taub, MD, is an Independent Director at BriaCell Therapeutics Corp.
She is on the Board of Directors at BriaCell Therapeutics Corp.
and Madrigal Pharmaceuticals, Inc. Dr. Taub was previously employed as a Chief Executive Officer & Director by Madrigal Pharmaceuticals, Inc. /Old/, a Senior Vice President-Research & Development by VIA Pharmaceuticals, Inc., a Vice President-Research & Metabolic Diseases by Hoffmann-La Roche, Inc., a Vice President-Research by Roche Pharmaceuticals, Inc., an Executive Director-CNS & Obesity Research by Bristol Myers Squibb Co., an Executive Director-CNS & Obesity Research by DuPont Pharmaceuticals Co., a Professor by Perelman School of Medicine, a Professor by University of Pennsylvania, an Assistant Professor by Harvard Medical School, and an Associate Investigator by Howard Hughes Medical Institute, Inc. She received her undergraduate degree from Yale College and a doctorate degree from Yale School of Medicine.